New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

The UK has seen a surge in the number of type 2 diabetes cases, with data analysis from Diabetes UK showing that one in five ...

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...

LOS ANGELES - A new clinical trial in The BMJ found that combining calorie restriction with the diabetes drug dapagliflozin reversed type 2 diabetes in nearly half of participants. The approach ...

“It makes sense that a diabetes medication, dapagliflozin, with calorie restriction would achieve better remission for type 2 diabetes than calorie restriction alone,” Cheng, who was not ...